Qiaoli Lv

Novel quinazoline-based dual EGFR/c-Met inhibitors overcoming drug resistance for the treatment of NSCLC: Design, synthesis and anti-tumor activity.

Pengwu Zheng, Wufu Zhu, Han Zhang, 2023, Bioorganic chemistry.

Rational design and synthesis of 2,4-dichloro-6-methyl pyrimidine derivatives as potential selective EGFRT790M/L858R inhibitors for the treatment of non-small cell lung cancer.

Y. Tu, Caolin Wang, Qingshan Pan, 2024, Archiv der Pharmazie.